TQB3454

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3454, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma. [Phase 3]